You Should Know These Things About Clover Health Investments Corp. (CLOV)


As of Wednesday close, Clover Health Investments Corp.’s (NASDAQ:CLOV) stock was down -$0.02, moving down -1.60 percent to $1.23. The average number of shares traded per day over the past five days has been 5,825,060 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.1400 fall in that time frame. In the last twenty days, the average volume was 7,933,475, while in the previous 50 days, it was 8,065,474.

Since last month, CLOV stock retreated -22.64%. Shares of the company fell to $1.2100 on 11/23/22, the lowest level in the past month. A 52-week high of $5.57 was reached on 01/03/22 after having rallying from a 52-week low of $1.21. Since the beginning of this year, CLOV’s stock price has dropped by -66.94% or -$2.4900, and marked a new high 1 time. However, the stock has declined by -77.92% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


CLOV stock investors should be aware that Clover Health Investments Corp. (CLOV) stock had its last reported insider trading activity 259 days ago on Mar 11. SHAPIRO LEE, the Director of the company, purchased of 80,000 shares for $3.10 on Mar 11. It resulted in a $248,072 investment by the insider. Clinton Chelsea added 100,000 shares at an average price of $2.53 on Mar 03. The insider now owns 100,000 shares following the transaction.

Financial Health

In the three months ended June 29, Clover Health Investments Corp.’s quick ratio stood at 1.30, while its current ratio was 1.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.05. In the year ended June 29, operating margins totaled -15.00%. Based on annual data, CLOV earned -$71.55 million in gross profit and brought in $1.47 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -114.70%. Return on equity (ROE) for the past 12 months was -95.90%.

In Clover Health Investments Corp.’s quarter-end financial report for June 29, it reported total debt of $19.97 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CLOV’s revenue rose 50.15% to $846.7 million during the quarter, while net income inched up to $856.82 million. While analysts expected Clover Health Investments Corp. to report -$0.21 quarterly earnings, the actual figure was -$0.22 per share, beating the consensus estimate by -4.80%. During the quarter, the company generated -$73.98 million in EBITDA. The liabilities of Clover Health Investments Corp. were 1.17 billion at the end of its most recent quarter ended June 29, and its total debt was $26.62 million. The value of shareholders’ equity is $477.94 million.

Technical Picture

This quick technical analysis looks at Clover Health Investments Corp.’s (CLOV) price momentum. With a historical volatility rate of 108.54%, the RSI 9-day stood at 35.18% on 23 November.

With respect to its five-day moving average, the current Clover Health Investments Corp. price is down by -10.22% percent or -$0.1400. At present, CLOV shares trade -21.15% below its 20-day simple moving average and -49.17% percent below its 100-day simple moving average. However, the stock is currently trading approximately -47.88% below its SMA50 and -55.43% below its SMA200.

Stochastic coefficient K was 8.28% and Stochastic coefficient D was 12.36%, while ATR was 0.1024. Given the Stochastic reading of 5.71% for the 14-day period, the RSI (14) reading has been calculated as 36.31%. As of today, the MACD Oscillator reading stands at -0.1133, while the 14-day reading stands at -0.1050.

Analyst Ratings

Cowen upgraded its rating on Clover Health Investments Corp. (NASDAQ: CLOV) to a Market perform in a note to investors on February 02, 2022. The analysts firm previously had an Underperform rating on the stock.Clover Health Investments Corp. (CLOV) has been rated Hold by analysts. According to 1 brokerage firm, CLOV is a sell, and 3 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Clover Health Investments Corp. stock as buy, with 1 recommending it as overweight.

With a median target price of $1.90, the current consensus forecast for the stock is $1.50 – $4.00. Based on these forecasts, analysts predict Clover Health Investments Corp. (CLOV) will achieve an average price target of $2.26.


Please enter your comment!
Please enter your name here